PRTC•benzinga•
PureTech Says It Will Present Results From Phase 2b ELEVATE IPF Trial Of Deupirfenidone (LYT-100) At American Thoracic Society International Conference, Regulatory And Strategic Planning Underway To Advance Deupirfenidone Into Phase 3 Development
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 1, 2025 by benzinga